Clinical Trial Update: Study of Bitopertin to Evaluate the Safety, Tolerability, Efficacy, and PPIX Concentrations in Participants With EPP [Phase 2]

View source ↗

Summary

Phase 2 study of Bitopertin in erythropoietic protoporphyria has completed, with results posted evaluating safety, tolerability, efficacy, and PPIX concentratio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erythropoietic Protoporphyria

Drugs mentioned

• Bitopertin (bitopertin)

Snippet

Sponsor: Disc Medicine, Inc | Conditions: Erythropoietic Protoporphyria | Phase 2 | Status: COMPLETED | Results posted: 2026-01-08